Emmessar Biotech & Nutrition Share Price

Emmessar Biotech & Nutrition Share Price

  • 25.170.17 (0.67%)
BSE
  • Closed
  • As On: 12 Jun, 2026, 03:45 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)28.86
EPS - TTM(₹)0.87
MCap(₹ Cr.)12.58
MCap Rank166
PB Ratio(x)1.54
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)42.90
52W Low(₹)18.42
MCap/Sales31.75
Beta(1 Month)0.11
BV/Share(₹)16.24

Emmessar Biotech share price insights

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 291.02% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Emmessar Biotech Share Price Update

    Emmessar Biotech & Nutrition Ltd. share price moved up by 0.67% from its previous close of Rs 25.00. Emmessar Biotech & Nutrition Ltd. stock last traded price is 25.17

    Share PriceValue
    Today/Current/Last25.17
    Previous Day25.00

Found Insights useful?

Emmessar Biotech Share Price Returns

1 Day0.67%
1 Month-2.71%
3 Months-1.29%
1 Year-23.52%
3 Years2.07%
5 Years-43.25%

Emmessar Biotech Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income0.570.580.630.630.70
    Total Income Growth (%)-2.91-7.490.54-10.8732.79
    Total Expenses0.490.450.490.400.44
    Total Expenses Growth (%)7.00-7.2323.92-11.0111.17
    EBIT0.080.130.140.230.26
    EBIT Growth (%)-37.83-8.38-39.28-10.6499.00
    Profit after Tax (PAT)0.030.120.110.17-0.07
    PAT Growth (%)-70.622.11-33.41--498.84
    EBIT Margin (%)14.1622.1222.3436.9936.89
    Net Profit Margin (%)6.0419.9618.0827.30-9.75
    Basic EPS (₹)0.010.230.230.34-0.16
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue2.412.622.552.772.28
    Total Revenue Growth (%)-8.132.84-8.0421.29-72.99
    Total Expenses1.831.661.731.801.35
    Total Expenses Growth (%)9.97-4.23-3.7933.34-78.20
    Profit after Tax (PAT)0.440.320.750.500.48
    PAT Growth (%)37.86-57.8248.795.98-67.21
    Operating Profit Margin (%)156.98156.94146.3694.86255.24
    Net Profit Margin (%)117.5551.75135.0149.43130.25
    Basic EPS (₹)0.810.611.480.990.94

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 291.02% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets9.539.228.747.947.21
    Total Assets Growth (%)3.365.4910.0810.12-7.68
    Total Liabilities1.421.511.341.281.04
    Total Liabilities Growth (%)-5.9612.694.6923.08-50.71
    Total Equity8.117.717.406.666.17
    Total Equity Growth (%)5.194.1911.117.948.25
    Current Ratio (x)20.2815.6713.5614.1414.73
    Total Debt to Equity (x)0.000.000.010.010.00
    Contingent Liabilities0.00----

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-0.350.220.640.382.27
    Net Cash used in Investing Activities0.35-0.23-0.64-0.55-2.61
    Net Cash flow from Financing Activities-0.00---
    Net Cash Flow0.020.0010,000.00-0.17-0.34
    Closing Cash & Cash Equivalent0.030.010.010.010.18
    Closing Cash & Cash Equivalent Growth (%)221.15-19.389.32-93.51-65.45
    Total Debt/ CFO (x)0.000.000.170.220.00

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)5.374.1010.127.557.70
    Return on Capital Employed (%)6.3610.969.8612.8513.53
    Return on Assets (%)4.573.428.576.346.58
    Interest Coverage Ratio (x)272.881,760.670.000.000.00
    Asset Turnover Ratio (x)0.040.070.070.130.05
    Price to Earnings (x)27.0348.3119.8424.6328.99
    Price to Book (x)1.451.972.011.862.23
    EV/EBITDA (x)6.537.879.646.878.94
    EBITDA Margin (%)183.98172.92163.94104.05280.54

    No Data Available

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters29,74,10559.53 %0.00
    Pledge00.00 %0.00
    DII2,6000.05 %0.00
    MF2,6000.05 %0.00
    Others20,19,39540.42 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters59.5359.5359.5359.53
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.050.050.050.05
    Mutual Funds0.050.050.050.05
    Others40.4240.4240.4240.42

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 05, 2026

    Board Meeting

    Quarterly Results

    Feb 04, 2026

    Board Meeting

    Quarterly Results

    Nov 06, 2025

  • Announced onMeeting on
    May 05, 2026May 12, 2026
    Audited Results
    Feb 04, 2026Feb 11, 2026
    Quarterly Results
    Nov 06, 2025Nov 12, 2025
    Quarterly Results
    Aug 04, 2025Aug 07, 2025
    Quarterly Results
    Apr 16, 2025Apr 24, 2025
    Audited Results
  • Announced onEx-DateDividend%
    Aug 05, 1999--
  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Sep 04, 2025Sep 26, 2025
    -
    Aug 14, 2024Sep 27, 2024
    -
    Nov 02, 2023Nov 24, 2023
    -
    Aug 24, 2023Sep 29, 2023
    A.G.M.
    Jul 05, 2022Aug 08, 2022
    Book closure from Aug 2, 2022 to Aug 8, 2022

About Emmessar Biotech

Emmessar Biotech & Nutrition Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 12.58 Crore) operating in Chemicals sector.

Show More

Key Indices Listed On

-

Address

Plot No.T-3/2,MIDC Area,Raigad District, Maharashtra - 410208

Executive Leadership

SR

Srinivasa Raghavan Mathurakavi Ayyangar

Managing Director
JB

Jeyavel B Nadar

Executive Director
AS

Anuradha S Raghavan

Non Executive Director
SS

Sarada S Raghavan

Non Executive Director
Show More

Auditors

V Nagarajan & Co.
V Sankar Aiyar & Co.

FAQs about Emmessar Biotech share

  • 1. What is Emmessar Biotech share price and what are the returns for Emmessar Biotech share?
    As on 12 Jun, 2026, 03:45 PM IST Emmessar Biotech share price is up by 0.67% basis the previous closing price of Rs 25.4. Emmessar Biotech share price is Rs 25.17. Return Performance of Emmessar Biotech Shares:
    • 1 Week: Emmessar Biotech share price moved up by 0.68%
  • 2. What are the returns for Emmessar Biotech share?
    Return Performance of Emmessar Biotech Shares:
    • 1 Week: Emmessar Biotech share price moved up by 0.68%
  • 3. What is the PE & PB ratio of Emmessar Biotech?
    The PE ratio of Emmessar Biotech stands at 28.66, while the PB ratio is 1.54.
  • 4. What is Emmessar Biotech's 52 week high / low?
    Emmessar Biotech share price saw a 52 week high of Rs 42.90 and 52 week low of Rs 18.42.
  • 5. What's the market capitalization of Emmessar Biotech?
    Market Capitalization of Emmessar Biotech stock is Rs 12.58 Cr.

Top Gainers

As on 04:06 PM | 12 Jun 2026
Ather Energy
1,028.70
714.90 (227.82%)
Netweb Technologies
4,587.40
2780.60 (153.90%)
Syrma SGS Technology
1,266.70
737.70 (139.45%)
Vodafone Idea
14.90
8.12 (119.76%)
GE T&D India
4,942.50
2633.90 (114.09%)

Top Losers

As on 03:58 PM | 12 Jun 2026
Tata Investment
665.90
-6218.10 (-90.33%)
Angel One
339.50
-2678.10 (-88.75%)
CAMS
757.55
-3315.15 (-81.40%)
Kotak Bank
403.30
-1723.50 (-81.04%)
Authum Investment
530.15
-1967.65 (-78.78%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.